These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36998748)

  • 1. Side-by-Side Comparison of Methods for Environmental Monitoring for Hazardous Drug Contamination.
    Hon CY
    Can J Hosp Pharm; 2023; 76(2):87-93. PubMed ID: 36998748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and reduction of hazardous drug surface contamination through the use of a novel closed-system transfer device coupled with a point-of-care hazardous drug detection system.
    Brechtelsbauer E
    Am J Health Syst Pharm; 2023 Mar; 80(7):435-444. PubMed ID: 36370411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of a Novel Qualitative Technique to Standard Quantitative Practices for Evaluation of Hazardous Drug Exposure in a Canadian Hospital Setting.
    Grewal R; Karas A; Goyal S
    Can J Hosp Pharm; 2024; 77(3):e3509. PubMed ID: 38988871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial and Temporal Variability in Antineoplastic Drug Surface Contamination in Cancer Care Centers in Alberta and Minnesota.
    Jeronimo M; Arnold S; Astrakianakis G; Lyden G; Stewart Q; Petersen A; Chambers C; Malard Johnson D; Zimdars E; Kaup H; Davies HW
    Ann Work Expo Health; 2021 Aug; 65(7):760-774. PubMed ID: 33889938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative LC-MS method to determine surface contamination of antineoplastic drugs by wipe sampling.
    Kåredal M; Jönsson R; Wetterling M; Björk B; Hedmer M
    J Occup Environ Hyg; 2022 Jan; 19(1):50-66. PubMed ID: 34723774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system.
    Hon CY; Teschke K; Demers PA; Venners S
    Ann Occup Hyg; 2014 Jul; 58(6):761-70. PubMed ID: 24644303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment.
    Yoshida J; Tei G; Mochizuki C; Masu Y; Koda S; Kumagai S
    Ann Occup Hyg; 2009 Mar; 53(2):153-60. PubMed ID: 19261696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of novel field measurement and field evaluation protocols for assessing health care workers' exposure risk to antineoplastic drugs.
    Astrakianakis G; Jeronimo M; Griffiths A; Colombo M; Kramer D; Demers PA; Hon CY
    J Occup Environ Hyg; 2020 Sep; 17(9):373-382. PubMed ID: 32615872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning.
    Chu WC; Hon CY; Danyluk Q; Chua PP; Astrakianakis G
    J Oncol Pharm Pract; 2012 Mar; 18(1):46-51. PubMed ID: 21737485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal evaluation of environmental contamination with hazardous drugs by surface wipe sampling.
    Sessink PJ; Tans B; Spriet I; Devolder D
    J Oncol Pharm Pract; 2024 Oct; 30(7):1181-1185. PubMed ID: 38115732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding.
    Soefje S; Rickabaugh K; Rajkumar R; Wall KP
    Int J Pharm Compd; 2021; 25(6):515-522. PubMed ID: 34807847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding.
    Soefje S; Rickabaugh K; Rajkumar R; Wall KP
    Int J Pharm Compd; 2022; 26(1):72-79. PubMed ID: 35081047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of chemical contamination by hazardous drugs with BD HD Check
    Valero García S; Centelles-Oria M; Palanques-Pastor T; Vila Clérigues N; López-Briz E; Poveda Andrés JL
    J Oncol Pharm Pract; 2022 Oct; 28(7):1583-1593. PubMed ID: 34565241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental contamination with hazardous drugs in quebec hospitals.
    Bussières JF; Tanguay C; Touzin K; Langlois E; Lefebvre M
    Can J Hosp Pharm; 2012 Nov; 65(6):428-35. PubMed ID: 23288952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineoplastic drug contamination of surfaces throughout the hospital medication system in Canadian hospitals.
    Hon CY; Teschke K; Chu W; Demers P; Venners S
    J Occup Environ Hyg; 2013; 10(7):374-83. PubMed ID: 23668810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental contamination by cyclophosphamide preparation: Comparison of conventional manual production in biological safety cabinet and robot-assisted production by APOTECAchemo.
    Schierl R; Masini C; Groeneveld S; Fischer E; Böhlandt A; Rosini V; Paolucci D
    J Oncol Pharm Pract; 2016 Feb; 22(1):37-45. PubMed ID: 25227229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Current Hazardous Drug Exposure Control in Community Pharmacy.
    Papastergiou J; Smiley T
    J Pharm Technol; 2022 Jun; 38(3):155-158. PubMed ID: 35600277
    [No Abstract]   [Full Text] [Related]  

  • 18. Surface wipe sampling for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings: Methodology and recommendations.
    Connor TH; Zock MD; Snow AH
    J Occup Environ Hyg; 2016 Sep; 13(9):658-67. PubMed ID: 27019141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verification of surface contamination of Japanese cyclophosphamide vials and an example of exposure by handling.
    Hama K; Fukushima K; Hirabatake M; Hashida T; Kataoka K
    J Oncol Pharm Pract; 2012 Jun; 18(2):201-6. PubMed ID: 21947739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.